A pulmonary embolism occurs when a clot breaks free and travels to the lungs
Statements and products are not intended to diagnose, treat, cure, or prevent any disease.
Johnson & Johnson (JNJ) CEO Joaquin Duato says his company has no plans to venture into the fast-growing market for GLP-1 obesity drugs and will instead focus on treatments for conditions such as cancer
This research comes on the heels of investigations by both American and European drug authorities into potential risks associated with GLP-1 analogs
The law was a response to the tragedy involving the New England Compounding Center, where contaminated compounded drugs caused a meningitis outbreak, killing more than 100 patients and sickening 800
Before we get started: if youre the type who reads three sentences and fades into the abyss, the info about connecting with our Peptide & Regenerative Medicine Performance Team is waiting for you at the end of this blog